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Apoptosis of THP-1 macrophage-derived foam cells induced by 5-aminolevulinic
acid-mediated sonodynamic therapy is mitochondria-caspase pathway
predominant despite the participation of endoplasmic reticulum stress
Wang Huan, Ye Tian
The ﬁrst afﬁliated hospital of Harbin Medical University
Objectives: In advanced atherosclerosis, chronic endoplasmic reticulum (ER) stress
induces foam cells apoptosis and generates inﬂammatory reactions. Sonodynamic
therapy (SDT) is a non-thermal synergistic method for cancer treatment utilizing
low-intensity ultrasound and sonosensitizers. 5-Aminolaevulinic acid (ALA) is the
biological precursor of sonosensitizer PpIX in the heme biosynthesis pathway in
mitochondria. In this study, we investigated the sub-cellular location of ALA-PpIX in
THP-1 macrophage-derived foam cells (FC) and the activation of mitochondria
pathway and ER stress induced by ALA-SDT.
Methods: FC were incubated with 1 mMALA. Fluorescence spectrometer was used to
detect the location and metabolism of ALA-PpIX in mitochondria and endoplasmic
reticulum (ER) of FC. Annexin V-PI staining was used to optimize ALA-SDT
treatment parameters by detecting the apoptotic and necrotic rates of FC induced by
ALA-SDT with different ALA incubation time and ultrasonic irradiation intensities.
Intracellular reactive oxygen species (ROS) level after ALA-SDT was detected
by staining with CellROX Green Reagent. Mitochondrial membrane potential
after ALA-SDT was detected by staining with JC-1. Pretreated with ROS inhibitor
N-acetylcysteine (NAC), pan-caspase inhibitor Z-VAD-FMK and ER stress inhibitor
4-phenylbutyrate (4-PBA), expressions of mitochondria apoptosis associated proteins
cytochromc c, cleaved caspase3, cleaved caspase9, Bcl-2, BAX and ER stress asso-
ciated protein C/EBP-homologous protein (CHOP) in FC after ALA-SDT were
detected by Western blotting.
Results: Accumulation of ALA-PpIX in mitochondria and ER reached peak at 6-hour,
and the ﬂuorescence intensity in mitochondria was triple of that in ER. The highest
percentage of apoptotic cells (63.6%9.8%) and the maximum apoptosis/necrosis
ratio (21.76.3) was observed at 5-hour after ALA-SDT with 6-hour incubation of
ALA and 0.4 W/cm2 ultrasound intensity. After ALA-SDT, intracellular ROS level
increased and the mitochondrial membrane potential collapsed. The translocations of
cytochrome c from mitochondria into cytosol and Bax from cytosol into mitochondria,
cleaved caspase 9, cleaved caspase 3, downregulation of Bcl-2, as well as upregulation
of CHOP were detected at 5-hour after ALA-SDT, which could be suppressed by
NAC. Activation of mitochondria apoptosis pathway could not be inhibited by 4-PBA.
Apoptosis induced by ALA-SDT could be inhibited by Z-VAD-FMK. 4-PBA reduced
FC apoposis by one third.
Conclusions: Mitochondria-caspase pathway is predominant in the apoptosis of FC
induced by ALA-SDT though ER stress participates in.
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SIRT1 protects against oxidative stress-induced endothelial progenitor cells
apoptosis by inhibiting FOXO3a via FOXO3a ubiquitination and degradation
Yu-Qiang Wang, Qing Cao, Fei Wang, Li-Ya Huang, Tian-Tian Sang, Shu-Yan Chen
Xinhua Hospital Afﬁliated to Shanghai Jiao Tong University School of Medicine
Objectives: Endothelial progenitor cells (EPCs) -based therapy holds tremendous
promise for the treatment of ischemic diseases. However, the function and survival of
EPCs are dramatically impaired by oxidative stress. SIRT1 plays important roles in
many pathophysiological processes such as apoptosis by deacetylation various sub-
strates, including FOXO. However, little is known about the roles of SIRT1 in the
regulation of EPCs apoptosis induced by H2O2. Our previous work showed that
FOXO3a could promote apoptosis of EPCs by transcriptional regulation of Bim. In the
present study, we investigated whether SIRT1 exerted a protective effect against
H2O2-induced EPCs apoptosis and whether SIRT1 deacetylation of FOXO3a could
facilitate FOXO3a ubiquitination and subsequent degradation.
Methods: EPCs were isolated and obtained from human umbilical cord blood by
density gradient centrifugation. Incubation of EPCs with H2O2 was used to induce
apoptosis. Apoptosis was determined by ﬂow cytometry and DNA fragmentation.
Western Blot analysis was used to examine the expression of SIRT1, FOXO3a, Bax
and cleaved caspase 3. Adenoviral-mediated transfection was used to overexpress or
downregulate SIRT1. Co-immunoprecipitation (co-IP) assay was performed to test the
interaction between SIRT1 and FOXO3a, FOXO3a acetylation level and FOXO3a
ubiquitination level.
Results: Immunoﬂuorescence showed that SIRT1 localized in the nuclear of EPCs in
the absence or presence of H2O2. SIRT1 expression in EPCs was increased by the
treatment with H2O2 (500mM) for 24 hours. Incubation of EPCs with H2O2 dose
dependently induced EPCs apoptosis. SIRT1 overexpression reduced H2O2-induced
EPCs apoptosis, while SIRT1 downregulation and EX527, a speciﬁc SIRT1 inhibitor,
exerted the opposite effect. SIRT1 overexpression decreased the total FOXO3a
expression, whereas SIRT1 downregulation and EX527 increased the amount ofJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BFOXO3a. Co-IP assay showed that SIRT1 could bind to FOXO3a, reduce its acety-
lation level and increase its ubiquitination level.
Conclusions: The results of our work demonstrated that SIRT1 had a pivotal pro-
tective role in the regulation of EPCs apoptosis induced by H2O2 and that SIRT1
protected against apoptosis by inhibiting FOXO3a via FOXO3a ubiquitination and
subsequent degradation.
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Pharmacogenetics of clopidogrel responsiveness in Chinese patients with acute
coronary syndrome
Tong Yin, Lanning Zhang, Xiaoqi Li, Li Peng, Cong Ma, Jie Yang, Yang Li,
Feng Cao, Yundai Chen, Caiyi Lu
Institute of Geriatric Cardiology, General Hospital of Chinese People’s Liberation
Army, Beijing, China
Objectives: Cytochrome P450 (CYP), ATP-binding cassette transporters (ABCB1),
and paraoxonase-1 (PON1) play crucial roles in clopidogel metabolism. Genetic
polymorphisms in these genes have been associated with the variability of the
response to clopidogrel, however, there are controversies over the ﬁndings. The
objective of the study is to elucidate the contribution of genetic polymorphisms in
CYP2C19, ABCB1, and PON1, to clopidogrel responsiveness in Chinese acute cor-
onary syndrome (ACS) patients.
Methods: Five hundred Chinese-Han patients treated with clopidogrel for ACS were
consecutively recruited. We assessed the relationships of CYP2C19*2, CYP2C19*3,
CYP2C19*17, PON1Q129R and ABCB1C3435T to the on-treatment platelet reac-
tivity (OTPR) after 5 days maintenance dose of clopidogrel administration, and the
risk for high on-treatment platelet reactivity (HPR, deﬁned as 20mmol/L ADP-induced
platelet aggregation>50%). In addition, clopidogrel responsiveness, measured by RI
[(pretreatment aggregation-posttreatment aggregation at 5 days) / (pretreatment ag-
gregation) x100%], was assessed in relation to the genotypes in a subgroup of 180
patients. RI values were stratiﬁed into four quartiles, with patients in quartile 1 deﬁned
as individuals of clopidogrel non-responsiveness.
Results: Both CYP2C19*2 and *3 were signiﬁcantly associated with higher OTPR
(P<10-5 and P¼0.04, respectively). OTPR in carriers of at least one CYP2C19
loss-of-function allele (*2 or *3, accounted for 58% of the study population) was
obviously higher than that in CYP2C19 wild type carriers (P<10-5). The carriers of
at least one CYP2C19 loss-of-function allele could predict greater risk of HPR
(adjusted OR: 1.79, 95% CI: 1.33-2.4, P¼0.003). Patients with CYP2C19*2 alone,
instead of CYP2C19*3, had a higher risk for HPR (adjusted OR: 1.56; 95% CI
1.04-2.33, P¼0.03). No signiﬁcant relation of CYP2C19*17, PON1Q192R and
ABCB1C3435T to OTPR and HPR was found in the cohort. In the subgroup of
180 patients, RI values were signiﬁcantly lower in patients with PON1 192 QR
and RR than in patients with QQ alleles (P¼0.01). PON1 192 QR and RR
conferred increased risk for clopidogrel non-responsiveness [adjusted OR: 3.64;
95% CI (1.21-10.92), P¼0.02]. A trend for lower RI values was shown in
CYP2C19*2 carriers compared to CYP2C19 wild type carriers (P¼0.06). An
increased risk for clopidogrel non-responsiveness was found in patients with
CYP2C19*2 [adjusted OR 2.02; 95% CI (1.03-3.96), P¼0.04]. No signiﬁcant
relation of CYP2C19*3, CYP2C19*17, and ABCB1C3435T to RI was found in
the subgroup of patients.
Conclusions: In conclusion, in clopidogrel treated Chinese patients with ACS,
carriers of at least one CYP2C19 loss-of-function allele could predict greater
risk for HPR, with the impact mainly attributing to CYP2C19*2. Both PON1
Q192R and CYP2C19*2 genotypes inﬂuence clopidogrel responsiveness, with the
impact of PON1 Q192R mainly on relative platelet inhibition instead of HPR of
clopidogrel.
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Effect of intracoronary or intravenous tiroﬁban bolus administration on platelet
activity and short time clinic beneﬁt in patients with acute ST-segment elevation
myocardial infarction undergoing emergency interventional treatment
Li Yi-Min1,2, Huang Jin2, Zhang Jing1, Lu Zhiping2, He Shenghu1
1Department of Cardiology, Northern Jiangsu People’s Hospital, Afﬁliated Hospital
to Yangzhou University, Yangzhou, 225001, China, 2Department of Cardiology,
Nanjing Chest Hospital, Nanjing 210029, China
Objectives: To investigate the effect on platelet activity and short time clinic beneﬁt
of intracoronary or intravenous tiroﬁban bolus administration to patients with acute
ST-segment elevation myocardial infarction undergoing emergency interventional
treatment.
Methods: Selected 90 patients with acute ST-segment elevation myocardial infarction
undergoing emergency interventional treatment, randomly divided into the intra-
coronary group (intracoronary tiroﬁban 10, 30 cases), intravenous group (intravenous
tiroﬁban 10 mg/kg bolus then 0.15 mg.kg-1.min-1 intravenous continuous infusion for
36 h, 30 cases) and control group (without tiroﬁban, 30 cases). The level of PMPs
were assessed before tiroﬁban infusion, at 10 min and 24 hours after tiroﬁban infusion,
and at 12 hours after stopping tiroﬁban infusion by the ﬂow cytometry. Clinical and
angiographic features were recorded and analyzed.
Results: There was no signiﬁcant difference in baseline of PMPs between intra-
coronary group, intravenous group and control group (P>0.05). The level of PMPs
were signiﬁcantly lower in intracoronary (3.6%2.3%) and intravenous groupasic and Translational Medicine C57
(5.1%2.7%) compared with control group (6.7%3.2%) (P <0.01 VS P¼0.04) at 10
mins after tiroﬁban infusion. The PMPs were also lower in intracoronary group than
intravenous group (P¼0.02). At 24 hours after tiroﬁban infusion, the PMPs of
intracoronary and intravenous group was similar (P>0.05) and was signiﬁcantly
higher than control group (P¼0.01 VS P ¼0.03) .PMPs was similar at 12 after
stopping tiroﬁban use among the 3 groups (P>0.05) .Intracoronary group were su-
perior to intravenous group and control group in terms of TIMI ﬂow grade (P¼0.03
VS P<0.01) and TIMI myocardial perfusion grade (P¼0.02 VS P<0.01) immediately
after PCI. MACEs rate in intracoronary group was lower than control group (P¼0.03) .And
MACEs rate between intracoronary group and intravenous group, intravenous group
and control group were similar (P>0.05, respectivly). The incidence of bleeding
events among 3 groups was similar.
Conclusions: Intracoronary tiroﬁban compared to the intravenous group, can effec-
tively reduce the number of PMPs in patients with acute ST-segment elevation
myocardial infarction undergoing emergency interventional treatment, achieve the
purpose of the inhibition of activated platelets quickly, and reduce total MACEs
events rate, but did not increase the risk of bleeding.
GW25-e0832
TNF receptor-associated factor 6 (TRAF6) mediates the angiotensin-induced
non-canonical TGFb pathway activation and differentiation of c-kit+ cardiac
stem cells
Cao Qing, Shuyan Chen
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Objectives: TNF receptor-associated factor 6 (TRAF6) acts as a multifunctional
regulator of the transforming growth factor (TGF) -b signaling pathway, and mediates
Smad-independent JNK and p38 activation via TGF-b. This study was performed to
test the hypothesis that TGF-b/TRAF6 is essential for angiotensin-II (Ang II) -induced
differentiation of rat c-kit+ cardiac stem cells (CSCs) .
Methods: c-kit+ CSCs were isolated from neonatal Sprague Dawley (SD) rats, and
their c-kit status was conﬁrmed with immunoﬂuorescence staining. A TGF-b type I
receptor inhibitor (SB431542) or the small interfering RNA (siRNA) -mediated
knockdown of TRAF6 were used to investigate the role of TRAF6 in TGF-b
signaling. Rescue of TRAF6 siRNA transfected cells with a 3’UTR deleted siRNA
insensitive construct was conducted to rule out the off target effects of the siRNA.
TRAF6 dominant negative (TRAF6DN) vector was constructed and used to infect c-
kit+ CSCs, and western blotting was used to assess the expression of TRAF6, JNK,
p38, cardiac-speciﬁc proteins, and Wnt signaling proteins. Physical interactions be-
tween TRAF6 and TGFb receptors were studied by coimmunoprecipitation.
Results: Cardiac differentiation was suppressed in the absence of TRAF6. Forced
expression of TRAF6 enhanced the expression of TGF-b-activated kinase1 (TAK1),
and inhibited Wnt signaling. Furthermore, TRAF6 increased the expression of car-
diac-speciﬁc proteins (cTnT and Cx-43) but inhibited the expression of Wnt3a.
Conclusions: Our data suggest that TRAF6 plays an important role in Ang II induced
differentiation of c-kit+ CSCs via the non-canonical signaling pathway.
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Effects of Herbal medicine Aconite Compound on Heart failure
Hou Xiujuan1, Sun Wenyan2, Li Geng3, Li Fangkai1, Ma Junfu1, Zhu Yuelan1
1Department of Rheumatology, Dongfang Hospital Afﬁliated to Beijing University of
Chinese Medicine, Beijing, China, 2College of Chinese Medicine, Beijing University
of Chinese Medicine, Beijing, China, 3Guangzhou University of Chinese Medicine,
Guangzhou, China
Objectives: Herbal medicine, also known as Chinese medicine, plays a role in
treatment of heart failure. Aconite, as one of Chinese medicine, is useful for treatment
of heart failure. purpose of this study is to test efﬁcacy of aconite compound in
improving heart funciton from both clinical and animal study to provide reference for
clinical application.
Methods: (1) Clinical study 41 Patients with chronic heart failure (CHF) were given
treatment of Chinese medicine aconite compound (twice daily for 8 weeks). Before
and after treatment, cardiac function (according to New York Heart Association
NYHA classiﬁcation method) and echocardiography (LVEF%) were observed; (2)
Animal study SD rats (SPF, male, 240 - 280g), acute heart failure model was used as
follows (isolated right carotid artery, heparin catheter was inserted through aortic
valve into left ventricular cavity, intravenous injection of nimodipine (0.6 mg/kg),
when left ventricular pressure maximal rate of rise (+LVdp/dtmax) decreased signif-
icantly, given treatment drugs, (Aconite compound dose as 7g/kg and duodenal
administration, and Cedilanid 0.2mg/kg, femoral vein injection), continue tracings 1h,
including before modeling, modeling immediately, after administration 10 mins, 20
mins, 30 mins, 40 mins, 50 mins, 60 mins to observe following indicators: left ven-
tricular systolic pressure (LVSP mmHg), left ventricular end-diastolic pressure
(LVEDP mmHg) .
Results: (1) 21 patients were male (44.9%), 20 patients were female (55.1%), mini-
mum age is 53 years, the maximum age is 95 years, mean age 73.88 +1.343 (years old),
P¼0.24>0.05, normal distribution; there was improvement of heart function acording
to before and after treatment echocardiography, the LVEF% Value was as follows:
44.71 +14.846 % VS 52.05 +14.854 %, t¼-2.669, P¼0.014<0.05; (2) Compared with
normal group, LVEDP (-0.290.57 vs 1.960.99, P<0.05) were signiﬁcantly higher,
LVSP (105.376.39 VS 129.007.47, P <0.01) was signiﬁcantly lower for acuteC58 JACC Vol 64/16/Suppl C j Octobheart failure group. After femoral vein injection cedilanid 0.2mg/kg, compared with
the model group, LVEDP decreased signiﬁcantly (-0.741.12 VS -0.531.18), LVSP
signiﬁcantly higher (107.737.49 VS 117.117.16 ) after the treatment at 10mins,
118.007.45 at 20 mins, 118.647.44 at 30mins, 120.058.25 at 40mins,
122.748.80 at 50 mins, 125.049.71 at 60mins), heart failure model copied suc-
cessfully; Aconite compound 7g/kg were administered orally to acute heart failure
rats, LVSP (105.376.39 in model group vs 112.365.83 at 10 mins, 115.696.29 at
20mins, 117.217.71 at 30mins, 118.3410.99at 40mins, 120.08 12.82 at 50mins,
123.9611.95 at 60mins), LVEDP (1.960.99 VS 0.050.87 at 10mins, -0.00 0.99
at 20 mins, -0.06 0.85 at 30mins, 0.02 0.84 at 40mins, 0.140.87at 50mins,
0.130.77 at 60 mins after the treatment) showed signiﬁcant improvement
(P<0.05;P<0.01).
Conclusions: Aconite compound can be used for the heart failure by improving hear
function, and there is no signiﬁcant side effects if it is used properly.
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Cardiosphere and Cardiosphere-Derived Cells Can Be Derived from The
Cadaver Autopsy
Wu Jian1,2, Sun Yong1,2, Tan Miaoxin1,2, Chi Di1,2, Zhang Maomao1,2, Kang Kai2,3,
Liu Fang1,2, Yu Bo1,2, Wu Jian1,2
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Objectives: Currently, cardiosphere (CSP) and cardiosphere-derived cells (CDCs) are
mainly obtained through myocardial biopsy and surgical, but there is limited access to
tissue size, technical requirements and faced with infection, trauma and other prob-
lems. We assume that there is still a large number cardiac stem cell survival in the
cadaver cardiac, we can get a sufﬁcient amount of functional CSPs and CDCs through
cadaver autopsy methods.
Methods: Mouse (C57BL/6) were sacriﬁced and placed in a refrigerator at 4 C for
0 to 3 days, cardiac tissue was removed at different time points (D0, D1, D2, D3), cut
into small pieces (approximately 1.5 cm3) and placed into dishes to culture explant-
derived cells (EDCs) with complete explant medium. Flow cytometry analysis the
expression of stem cell surface markers of EDCs such as CD117, CD133, CD105,
Sca-1, CD90. EDCs were cultured with Cardiosphere growth medium to form CSP.
CD105, CD117, GATA-4, Nkx2.5 and Connexin-43 were detected by immunoﬂuo-
rescence. CSP was placed in ﬁbronectin covered ﬂasks and grow into a layer of CDCs.
Early cardiac transcription factors GATA-4, Nkx2.5 and Connexin-43 were detected
by polymerase chain reaction (PCR), cardiac stem cell surface markers CD117 and
Sca-1 were tested by ﬂow cytometry. The proliferation ability was tested by cck-8, c-
TnI and vWF were stained by immunoﬂuorescence after induction of differentiation.
Results: Nine days after placing the cardiac tissue in dishes, EDCs from mouse
cadaver cardiac were successfully isolated and cultured. Each group of EDCs are rich
in stem cell surface markers expressing such as CD117, CD133, CD105, Sca-1,
CD90, and could culture into CSP and CDCs. With the extension of the dead days, the
number of EDCs was able to harvest from the autopsy gradually decreased, the
amount of EDCs could harvest at D3 decreased signiﬁcantly (the number of each 60
mm dishes at D0, D1, D2, D3 were 86.005.27104, 66.923.15104,
49.673.17104, 23.751.52104, respectively). There is no signiﬁcant differences
in CD117 and Sca-1 expression at D0 and D1 in EDCs and CDCs, but decreased at D2
and D3. No signiﬁcant difference was found in the ability of EDCs to form CSPs (the
number of each well of 24-well plate at D0, D1, D2, D3 were 38.331.25,
38.002.45, 37.331.25, 38.002.16, respectively), and each group of CSPs was
positive expression CD117, CD105, GATA-4, NKX2.5 and Connexin-43. CDCs
obtained from cadaver autopsy both express GATA-4, Nkx2.5 and Connexin-43 when
detected by PCR and immunoﬂuorescence, but decreased in D2 and D3. There is no
signiﬁcant difference in proliferation when detect by cck-8 and c-TnI, vWF expression
after induction of CDCs.
Conclusions: There is a variety of stem cells survival in cadaveric cardiac even at three
days post-mortem. EDCs harvested through cadaver autopsy methods can form enough
CSPs and CDCs. CDCs from cadaver autopsy also have strong ability of proliferation
and differentiation. CSPs and CDCs obtained from cadaver autopsy may be used as a
source or alternative sources of allograft transplantation and needs further research in
vivo, which may solve the insufﬁcient source problems existing in cardiac stem cells.
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Statin effects on UA patients microRNA expression proﬁle and regulatory
functional network analysis
Li Jingjin, Chongyou Lee, Feng Zhang, Jingyi Ren, Hong Chen
Peking university people’s hospital
Objectives: Unstable angina (UA), an acute coronary syndrome caused by disruption
of atherosclerotic plaque triggered thrombosis. The blood vessel narrow and reduction
of blood ﬂow induce the symptom. Statin therapy beneﬁts UA patients by cholesterol
independent effect. Yet the mechanism of statin pleiotropic effect remained to be
study. MicroRNAs (miRNAs), small non-coding RNAs, are post-transcriptional
regulators of gene expression. In this study we aim to investigate statins’ novel
mechanism mediated by miRNAs. Moreover we carry out systematic analysis of the
miRNAs functional networks in atherosclerotic lesions.er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
